BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
13 results:

  • 1. Cost-Effectiveness Analysis of Adjuvant Therapy for BRAF-Mutant Resected Stage III Melanoma in Medicare Patients.
    Mojtahed SA; Boyer NR; Rao SA; Gajewski TF; Tseng J; Turaga KK
    Ann Surg Oncol; 2021 Dec; 28(13):9039-9047. PubMed ID: 34129153
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of High-Intensity Focused Ultrasound and Conventional Surgery for Patients with Uterine Myomas: A Systematic Review and Meta-Analysis.
    Tsai MC; Chang LT; Tam KW
    J Minim Invasive Gynecol; 2021 Oct; 28(10):1712-1724. PubMed ID: 34126271
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications.
    Mandel VD; Medri M; Manganoni AM; Pavoni L; De Rosa F; Ribero S; Foca F; Andreis D; Mazzoni L; Magi S; Farnetani F; Palla M; Ulivi P; Stanganelli I
    J Dermatolog Treat; 2022 May; 33(3):1368-1375. PubMed ID: 32875931
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
    Geoerger B; Kang HJ; Yalon-Oren M; Marshall LV; Vezina C; Pappo A; Laetsch TW; Petrilli AS; Ebinger M; Toporski J; Glade-Bender J; Nicholls W; Fox E; DuBois SG; Macy ME; Cohn SL; Pathiraja K; Diede SJ; Ebbinghaus S; Pinto N
    Lancet Oncol; 2020 Jan; 21(1):121-133. PubMed ID: 31812554
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study.
    Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Wang X; Li L
    PLoS One; 2019; 14(7):e0220047. PubMed ID: 31314797
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
    Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
    Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
    Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
    Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.
    Abdel-Rahman O; Fouad M
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):751-60. PubMed ID: 24666215
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide.
    Dimopoulos MA; Richardson PG; Brandenburg N; Yu Z; Weber DM; Niesvizky R; Morgan GJ
    Blood; 2012 Mar; 119(12):2764-7. PubMed ID: 22323483
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry.
    Hillner BE; Siegel BA; Shields AF; Liu D; Gareen IF; Hunt E; Coleman RE
    J Nucl Med; 2008 Dec; 49(12):1928-35. PubMed ID: 18997054
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
    Chandrashekar NS; Hiremath SR
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):235-9. PubMed ID: 18221066
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. What is the current role of radiation therapy in the treatment of skin carcinomas?
    Finizio L; Vidali C; Calacione R; Beorchia A; Trevisan G
    Tumori; 2002; 88(1):48-52. PubMed ID: 12004850
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
    Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
    N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.